España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
CEL-SCI
CVM
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.7299
-0.04
-4.60%
At close: -
$0.7748
0.04
6.15%
After Hours: Dec 20, 7:26 PM EDT
Get Report
Comment
CEL-SCI (CVM) Forecast
News
Earnings
CEL-SCI (CVM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for CEL-SCI (AMEX:CVM) Stock
CEL-SCI Stock (AMEX: CVM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 12, 2024
CEL-SCI Announced Multikine Demonstrates Tumo...
Benzinga Newsdesk
Monday, December 09, 2024
Watching CEL-SCI; Zacks Small-Cap Research Gi...
Benzinga Newsdesk
Thursday, November 07, 2024
CEL-SCI And U.S. FDA Approve Use Of PD-L1 Bio...
Benzinga Newsdesk
Tuesday, October 22, 2024
CEL-SCI Announces The Potential Impact On The...
Benzinga Newsdesk
Tuesday, October 01, 2024
CEL-SCI Reveals Renewed Collaboration With Er...
Benzinga Newsdesk
Monday, September 16, 2024
CEL-SCI Reported New Data From Its Concluded ...
Benzinga Newsdesk
Tuesday, September 10, 2024
CEL-SCI To Present Data for Multikine Head & ...
Benzinga Newsdesk
Wednesday, September 04, 2024
The UK's MHRA Grants CEL-SCI's Multikine A Pr...
Benzinga Newsdesk
Thursday, August 15, 2024
CEL-SCI Q3 2024 Adj EPS $(0.14) Misses $(0.11...
Benzinga Newsdesk
Friday, July 26, 2024
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
CEL-SCI Shares Resume Trade
Benzinga Newsdesk
CEL-SCI Shares Halted On Code News Pending
Benzinga Newsdesk
CEL-SCI Prices $10.845M Best-Efforts Offering...
Benzinga Newsdesk
CEL-SCI shares are trading higher after the c...
Benzinga Newsdesk
CEL-SCI's Phase 3 Population Analysis For Con...
Benzinga Newsdesk
Monday, July 08, 2024
CEL-SCI Appoints Robert Watson As Chairperson...
Benzinga Newsdesk
Tuesday, June 18, 2024
CEL-SCI Presents Head & Neck Cancer Data At I...
Benzinga Newsdesk
Thursday, May 16, 2024
CEL-SCI Q2 2024 GAAP EPS $(0.28) Misses $(0.1...
Benzinga Newsdesk
Thursday, May 09, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, May 08, 2024
Why CEL-SCI (CVM) Shares Are Trading Higher
Henry Khederian
CEL-SCI shares are trading higher after the c...
Benzinga Newsdesk
CEL-SCI Receives FDA Approval For Its Confirm...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Wednesday, March 06, 2024
CEL-SCI Corporation Issues Letter To Sharehol...
Benzinga Newsdesk
Thursday, February 15, 2024
CEL-SCI Q1 EPS $(0.14) Up From $(0.18) YoY
Benzinga Newsdesk
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why CEL-SCI Corporation (CVM) Shares Are Diving
Henry Khederian
Cel-Sci shares are trading lower after the co...
Benzinga Newsdesk
CEL-SCI Announces Pricing Of $7.75M Public Of...
Benzinga Newsdesk
Wednesday, January 31, 2024
European Medicines Agency Grants CEL-SCI A Wa...
Benzinga Newsdesk
Thursday, December 28, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, December 22, 2023
CEL-SCI Clocks FY23 EPS Loss of $(0.73) Vs $(...
Benzinga Newsdesk
Monday, December 04, 2023
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
CEL-SCI shares are trading higher after the c...
Benzinga Newsdesk
Why Is Cancer Focused CEL-SCI Stock Trading Higher Today?
Vandana Singh
UK'S National Institute for Health And Care E...
Benzinga Newsdesk
Thursday, November 16, 2023
CEL-SCI Prices 2.49M Share Offering To A Sing...
Benzinga Newsdesk
Monday, October 30, 2023
CEL-SCI Issues Letter To Shareholders
Benzinga Newsdesk
Tuesday, October 24, 2023
CEL-SCI Releases Video Detailing Recent Phase...
Benzinga Newsdesk
Monday, October 23, 2023
CEL-SCI Corporation Announces 5-Year Head & Neck Cancer Survival Increased From 45% To 73% In Co's Target Population, Cutting Risk Of Death In Half, As Presented At Leading Cancer Conference ESMO 2023
Happy Mohamed
Thursday, October 05, 2023
CEL-SCI Files Request With The UK's MHRA Rega...
Benzinga Newsdesk
Tuesday, September 26, 2023
Cel-Sci Submits Scientific Advice Filing To E...
Benzinga Newsdesk
Monday, August 14, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, August 11, 2023
CEL-SCI Q3 EPS $(0.19) Misses $(0.16) Estimate
Happy Mohamed
Monday, August 07, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Monday, July 31, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, July 28, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, July 25, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, July 24, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch